Metsera

Kailera

This biopharmaceutical company develops injectable and oral therapies for the treatment of obesity and related metabolic conditions.

Ousia Pharma

This biotechnology company develops peptide-drug conjugates to treat obesity and cardiometabolic diseases for patients requiring improved metabolic health and weight regulation.

Fable Therapeutics

The company develops protein-engineered biologics using machine learning to treat patients with obesity and metabolic diseases.

Tanai Therapeutics

This company develops oral small molecule therapeutics targeting energy expenditure pathways to treat obesity and cardiometabolic diseases for patients.

Ambrosia Biosciences

This drug discovery company develops orally delivered small-molecule therapies for obesity and metabolic disorders for patients requiring alternatives to injectable treatments.

Metabolys

This biopharmaceutical company develops oral small molecules to treat metabolic diseases, specifically non-alcoholic steatohepatitis and type 2 diabetes, for the global healthcare market.

Prolynx

The company develops long-acting medicines for obesity and metabolic conditions using proprietary drug delivery technology for patients requiring less frequent dosing.

Hawkhill Therapeutics

This company develops oral small molecule therapies for obesity and metabolic health to preserve muscle mass for the biotechnology and pharmaceutical sectors.